CONRADO YUTUC: Open Payments
NPI 1447971486 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,306 in 86 payments from 16 companies in 2025. Trend: 2023 $527 · 2024 $1,907 · 2025 $2,306
Food & beverage: $2,306
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $325 |
| AstraZeneca Pharmaceuticals LP | 11 | $281 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $279 |
| Sumitomo Pharma America, Inc. | 2 | $238 |
| Kowa Pharmaceuticals America, Inc. | 8 | $226 |
| Novo Nordisk Inc | 11 | $202 |
| GlaxoSmithKline, LLC. | 8 | $182 |
| PFIZER INC. | 8 | $150 |
| Lilly USA, LLC | 9 | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $73 |
Products named: QULIPTA, Kerendia, GEMTESA, ZORYVE, AIRSUPRA, TRELEGY ELLIPTA, PREVNAR 20, JARDIANCE.
Industry payments across NV — which companies pay providers there.
